|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 8.640 USD | -4.64% |
|
-13.69% | -70.06% |
| 09-01 | Capricor Therapeutics Shares Rise After Piper Sandler Upgrade | MT |
| 09-01 | Piper Sandler Upgrades Capricor Therapeutics to Overweight From Neutral, Adjusts PT to $25 From $2 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 527M | - | - | - | - | - |
| 69.19B | |||||
| 62.97B | |||||
| 27.27B | - | ||||
| 24.78B | - | ||||
| 25.8B |
Select your edition
All financial news and data tailored to specific country editions
